Efficiency of combined endocrine therapy with CDK4/6 inhibitors in metastatic HR<sup>+</sup>/HER2<sup>-</sup> breast cancer: Immunological aspects

Efficiency of combined endocrine therapy with CDK4/6 inhibitors in metastatic HR<sup>+</sup>/HER2<sup>-</sup> breast cancer: Immunological aspects

Luminal HER2-negative subtypes of breast cancer have always attracted oncologists due to their sensitivity to low-toxicity hormone therapy. The emergence of new inhibitors of cyclin-dependent kinases has allowed hormone therapy to achieve optimal control of tumor growth, being prescribed even for vi...

Full description

Saved in:
Bibliographic Details
Main Authors: A. V. Sultanbaev, I. A. Tuzankina, I. V. Kolyadina, A. F. Nasretdinov, Sh. I. Musin, N. I. Sultanbaeva, K. V. Menshikov, A. A. Izmailov, M. V. Sultanbaev, D. A. Kudlay
Format: Article
Language:Russian
Published: St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2025-07-01
Series:Медицинская иммунология
Subjects:
hr<sup>+</sup>/her2<sup>-</sup> breast cancer
cdk4/6 inhibitors
endocrinotherapy
antitumor immunity
trec
krec
Online Access:https://www.mimmun.ru/mimmun/article/view/3199
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items